Membranous glomerulonephritis and myelodysplastic syndrome;Glomérulonéphrite extramembraneuse et syndrome myélodysplasique

Nephrologie

Volumn 25, Issue 2, 2004, Pages 59-61

  Doukkali, O ^a,b   Tarrass, F ^a   Medkouri, G ^a   Fatihi, E ^a   Ramdani, B ^a   Zaid, D ^a   Azzouzi, S ^a   Sqalli, S ^a  

^a IBN ROCHD UNIVERSITY HOSPITAL   (Morocco)

^b NONE   (Morocco)

Author keywords

Membranous glomerulonephritis; Myelodysplastic syndrome; Tumor necrosis factor

Indexed keywords

CORTICOSTEROID; CYTOKINE; FAS ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; BLOOD CELL COUNT; BONE MARROW CELL; CASE REPORT; CELL COUNT; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; GLOMERULONEPHRITIS; HISTOPATHOLOGY; HUMAN; IDIOPATHIC DISEASE; KIDNEY BIOPSY; MALE; MEMBRANOUS GLOMERULONEPHRITIS; MYELODYSPLASTIC SYNDROME; NEPHROTIC SYNDROME; PATHOPHYSIOLOGY; PROTEINURIA; QUALITATIVE ANALYSIS; REVIEW;

ADRENAL CORTEX HORMONES; ADULT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; GLOMERULONEPHRITIS, MEMBRANOUS; HUMANS; MALE; MYELODYSPLASTIC SYNDROMES; NEPHROTIC SYNDROME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 1942424097     PISSN: 02504960     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (17)

1. Paydas S, Paydas S, Tuncer I, Zorludemir S, Gonlusen G. A case with membranous glomerulonephritis and myelodysplastic syndrome. Nephron 1992; 62: 231-2.
2. Heaney ML, Golde DW. Myelodysplasia. N Engl J Med 1999; 340: 1649-60.
3. Molnar L, Berki T, Hussain A, Nemeth P, Losonczy H. Detection of TNF alpha expression in the bone marrow and determination of TNF alpha production of peripheral blood mononuclear cells in myelodysplastic syndrome. Pathol Oncol Res 2000; 6: 18-23.
4. Enright. H, Jacob HS, Vercelloti G, Howe R, Belzer M. Miller W. Paraneoplastic autoimmune phenomena in patients with myelodysplastic syndromes: Response to immunosuppressive therapy. Br J Haematol 1995; 91: 403-8.
5. Bogdanovi R, Kuzmanovic. M, Markovic-Lipkovski J, et al. Glomerular involvement in myelodysplastic syndromes. Pediatr Nephrol 2001; 16: 1053-7.
6. Saitoh T, Murakami H, Uchiumi H, et al. Myelodysplastic syndromes with nephrotic syndrome. Amer J Hematology 1999; 60: 200-4.
7. Hayashi S, Okada T, Tsutsuma H, Kumakawa T, Mori M. A case of myelodysplastic syndrome associated with IgA nephropathy. Nippon Ronen Igakkai Zasshi 1999; 36: 373-6.
8. Komatsuda A, Miura I, Obtain H, et al. Crescentic glomerulonephritis accompanied by myeloperoxidase anti-neutrophil cytoplasmic antibodies in a patient having myelodysplastic syndrome with trisomy 7. Am J Kidney Dis 1998; 31: 336-40.
9. Morschhauser F, Wattel E, Pagniez D, Loui V, Rose C, Bauters Fenaux P. Glomerular injury in chronic myelomonocytic leukemia. Leuk- Lymphoma 1995; 18: 479-83.
10. Wu TH, Tsai CY, Yang WC. Excessive expression of the tumor necrosis factor-alpha gene in the kidneys of patients with membranous glomerulonephritis. Zhonghua Yi Xue Za Zhi (Taipei) 1998; 61: 524-30.
11. Neale TJ, Ruger BM, Macaulay H, et al. Tumor necrosis factor-alpha is expressed by glomerular visceral epithelial cells in human membranous nephropathy. Amer J Pathol 1995; 146: 1444-54.
12. Kitagawa M, Saito I, Kuwata T, et al. Overexpression of tumor necrosis factor (TNF)-alpha and interferon (IFN)-gamma by bone marrow cells from patients with myelodysplastic.syndromes. Leukemia 1997; 11: 2049-54.
13. Zombos N, Symeonidis A, Kourakli A, et al. Increased levels of soluble interleukin-2 receptors and tumor necrosis factor in serum of patients with myelodysplastic syndromes. Blood 1991; 77: 413-4.
14. Verhoef GE, De Schouwer P, Ceuppens JL, Van Damme J, Goossens W, Boogaerts MA. Measurement of serum cytokine levels in patients with myelodysplastic syndromes. Leukemia 1992; 6: 1268-72.
15. Raza A, Mundle S, Shetty V, et al. Novel insights into the biology of myelodysplastic syndromes: Excessive apoptosis and the role of cytokines. Int J Hematol 1996; 63: 265-78.
16. Hellström-Lindberg E, Willman C, Barrett AJ, Saunthararajah Y. Achievements in understanding and treatment of myelodysplastic syndromes. Hematology 2000; 1: 110-32.
17. Gersuk GM, Beckham C, Loken MR, et al. A role for tumour necrosis factor-alpha, Fas and Fas-Ligand in marrow failure associated with myelodysplastic syndrome. Br J Haematol 1998; 103: 176-88.